Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Treatment Of Hemifacial Spasm With Botulinum Toxin

D. Yoshimura, M. Aminoff, T. Tami, A. Scott
Published 1992 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The effectiveness of botulinum toxin injections in 11 patients with hemifacial spasm was investigated in a prospective placebo‐controlled blinded study. The patients were treated with four sets of injections to various facial muscles, selected by clinical evaluation. Three injections were with graded doses of toxin and one was with placebo. The order of injections was random and unknown to the patients. Results were scored both subjectively by patient assessment of symptoms and objectively by blinded review of videotapes made one month after each injection. Subjective improvement occurred after 79% of injections with botulinum toxin, regardless of dose of toxin. Only 1 patient improved after placebo. Objective improvement was seen after 84% of injections with botulinum toxin. No patient showed objective improvement after placebo injection. The most frequent side effect was facial weakness, seen after 97% of injections of botulinum toxin. Facial bruising (20%), diplopia (13%), ptosis (7%), and various other mild side effects were seen less frequently. Botulinum toxin appears to be an effective and safe method of therapy for hemifacial spasm. © 1992 John Wiley & Sons, Inc.
This paper references
10.1212/WNL.40.9.1332
Assessment: The clinical usefulness of botulinum toxin‐A in treating neurologic disorders
Lippincott Williams Wilkins (1990)
10.1002/MUS.880120904
Botulinum toxin therapy in hemifacial spasm: Clinical and electrophysiologic studies
B. D. Geller (1989)
10.1159/000153952
Distribution of human Zn-alpha-2-glycoprotein types in Chinese and Korean populations.
M. Ding (1990)
10.1212/WNL.37.4.616
Botulinum A toxin for cranial‐cervical dystonia
J. Jankovic (1987)
10.1001/ARCHOTOL.1988.01860240057024
Management of facial spasm with Clostridium botulinum toxin, type A (Oculinum)
A. W. Biglan (1988)
10.1136/jnnp.52.3.355
Treatment of focal dystonias of the hand with botulinum toxin injections.
L. Cohen (1989)
10.1002/MDS.870020402
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
M. Brin (1987)
10.1001/ARCHOTOL.1987.01860060029009
Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report.
R. Miller (1987)
10.1001/ARCHOPHT.1985.01050090057031
Hemifacial spasm treated with botulinum A toxin injection.
P. Savino (1985)
10.1017/S0317167100027748
Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations.
S. Kraft (1988)
10.1212/WNL.39.1.80
Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis
D. Gelb (1989)
10.1016/S0140-6736(86)92070-2
DOUBLE-BLIND STUDY OF BOTULINUM TOXIN IN SPASMODIC TORTICOLLIS
J. C. Tsui (1986)
10.1136/jnnp.51.7.920
Botulinum toxin in spasmodic torticollis.
R. Stell (1988)
10.1016/S0161-6420(86)33641-8
Treatment of facial spasm with botulinum toxin. An interim report.
B. Frueh (1986)
10.1212/WNL.35.10.1499
Blepharospasm, Meige syndronfie, and hemifacial Spasm
J. Mauriello (1985)
10.1001/ARCHOPHT.1984.01040031184014
Treatment of blepharospasm with botulinum toxin. A preliminary report.
B. Frueh (1984)
10.3171/JNS.1977.47.3.0321
Etiology and definitive microsurgical treatment of hemifacial spasm. Operative techniques and results in 47 patients.
P. Jannetta (1977)
10.1212/WNL.38.8.1220
Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia
C. Ludlow (1988)



This paper is referenced by
10.1177/014556131809700303
An Atypical Presentation of Hemifacial Spasm Secondary to Neurovascular Compression
E. Palacios (2018)
10.1093/QJMED/95.8.493
Hemifacial spasm and involuntary facial movements.
N. Tan (2002)
10.1111/j.1600-0404.1996.tb07053.x
Botulinum toxin A injection in the treatment of hemifacial spasm
R. S. Chen (1996)
10.1177/197140099400700314
Neurovascular Conflict of the CP Angle: 3D-FT High Definition MR Analysis
N. Girard (1994)
10.1002/14651858.CD004899.PUB2
Botulinum toxin type A therapy for hemifacial spasm.
J. Costa (2005)
10.1055/S-0043-104698
Therapie des Spasmus hemifacialis mit Botulinumtoxin
W. Jost (2017)
10.1007/s11910-014-0512-2
An Update and Review of the Treatment of Myoclonus
K. Mills (2014)
10.1016/B978-012125831-3/50273-2
Chapter 78 – Dyskinesias
H. Topka (2003)
10.1016/J.PARKRELDIS.2006.06.002
Botulinum toxin: clinical use.
D. Truong (2006)
Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
A. Suputtitada (2004)
10.1007/978-3-7091-6829-5_16
Hemifacial spasm: treatment with botulinum toxin (a report of 50 patients)
C. Vial (1997)
10.1016/B978-0-323-05283-2.00173-7
Rehabilitation of Facial Paralysis
J. Ridgway (2010)
10.1097/00006534-199902000-00045
Nonsurgical Treatment of Platysmal Bands with Injection of Botulinum Toxin A
M. Kane (1999)
10.1006/exnr.2000.7583
Botulinum A Toxin: Dysport Improvement of Biological Availability
H. Bigalke (2001)
10.1055/a-0834-4188
[Therapy of Hemifacial Spasm with Botulinum Toxin].
W. Jost (2019)
10.1007/s00702-020-02183-1
Evaluation of botulinum toxin effects in hemifacial spasm patients: correlation between clinical rating scales and high-speed video system measurements
T. Osaki (2020)
10.1016/j.jns.2015.06.032
Hemifacial spasm: The past, present and future
N. Chaudhry (2015)
10.1007/s00702-007-0768-7
Botulinum toxin in the treatment of blepharospasm and hemifacial spasm
C. Kenney (2007)
10.1016/S0090-6980(01)00168-X
Latanoprost in hemifacial spasm.
L. Crevits (2002)
10.1007/978-981-15-5417-9_13
Botulinum Toxin Injection in Hemifacial Spasm
Jinyoung Youn (2020)
10.1002/ANA.410350218
Botulinum toxin‐A improves the rigidity of progressive supranuclear palsy
K. B. Polo (1994)
10.1016/S1567-4231(09)70189-3
Chapter 41 Focal injection therapy
Jean-Michel Gracies (2003)
10.1016/j.jocn.2015.02.032
Botulinum toxin injections for the treatment of hemifacial spasm over 16years
M. Sorgun (2015)
10.1177/197140099500800623
Treatment of vertebro-basilar dissecting aneurysms using intravascular stents.
S. Yamasaki (2006)
10.1007/s002340050366
Three-dimensional MRI of hemifacial spasm with surgical correlation
N. Girard (1997)
10.1007/s11910-012-0286-3
Botulinum Toxin for the Treatment of Movement Disorders
M. A. Thenganatt (2012)
10.1007/978-1-59259-410-8_31
Botulinum Toxin Treatment of Movement Disorders
C. Adler (2000)
10.1007/s11910-010-0129-z
An Update on the Neurologic Applications of Botulinum Toxins
V. Evidente (2010)
10.1016/B978-1-4160-4665-3.00044-5
Chapter 44 – Operations for Vascular Compressive Syndromes
P. Jannetta (2010)
10.1016/j.toxicon.2012.12.004
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
M. Hallett (2013)
10.1016/B978-1-4160-4928-9.00010-X
Chapter 10 – Botulinum Neurotoxin in Tremors, Tics, Hemifacial Spasm, Spasmodic Dysphonia, and Stuttering
A. Bentivoglio (2009)
10.1054/jocn.2000.0684
The current use of botulinum toxin
N. Mahant (2000)
See more
Semantic Scholar Logo Some data provided by SemanticScholar